|
|
Home >
Anti-aging Research > Evening Primrose
Evening Primrose (Oenothera biennis)
Specific Recommendations:
News & Research:
- GLA (Gamma-Linolenic Acid) - The Natural
Pharmacist
- Can I Stop My Hair from
Thinning? - Dr. Weil, 9/13/02 -
"Make sure you’re getting enough
omega-3
fatty acids ... supplement your diet with
GLA (gamma-linolenic acid) in the
form of black currant oil or evening primrose oil"
-
Healing Skin and Coat Conditions - Nutrition Science News, 10/01
-
PUFAs for Bone Growth and Repair - Nutrition Science News, 3/01
-
Ten Things You Can Do To Stop Hair Loss With Thyroid Disease -
About.com, 6/10/99 (talks about EPO about two thirds down)
Related Sites:
-
Evening primrose seed
extract rich in polyphenols modulates the invasiveness of colon cancer cells by
regulating the TYMS expression - Food Funct 2022 Oct 14 -
"The inhibition of metastasis correlated with a decrease
in thymidylate synthetase (TYMS), which has recently been associated with
metastatic phenotype development. Our results indicate that the EPE might be an
effective anticancer agent in suppressing colon cancer metastasis regardless of
the invasiveness cause. Based on these findings, we concluded that the used EPE
extract rich in polyphenols inhibits cell invasion by TYMS downregulation"
- See evening primrose oil
at Amazon.com.
-
Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose
Oil in Patients with Atopic Dermatitis - Adv Ther. 2014 Jan 17 -
"Atopic dermatitis (AD) has been related to a
deficiency of delta-6-desaturase, an enzyme responsible for the conversion
of linoleic acid to gamma-linolenic acid (GLA). Evening primrose oil (EPO)
contains high amounts of GLA. Therefore, this study investigated whether EPO
supplementation results in an increase in plasma GLA and its metabolite
dihomo-gamma-linolenic acid (DGLA) correlating with clinical improvement of
AD, assessed by the SCORing Atopic Dermatitis (SCORAD) index ... The
clinical disease activity under EPO treatment correlates with the individual
increase in plasma GLA levels. Thus, the results of this pilot study
indicate that an increase in plasma GLA might be used as predictive
parameter for responsiveness of AD to EPO therapy"
|
|